Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Purchase of 27,777 BRVE shares, $500.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Braveheart Bio, Inc. (BRVE) | Purchase | 27,777 | $500.0K |
| May 20, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Disposition to Issuer | 26,761 | n/a |
| May 9, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Exercise/Conversion | 1 | $7.55 |
| Jan 29, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Exercise/Conversion | 236 | $1.5K |
| Jan 5, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/Award | 31,200 | n/a |